Buy Tirzepatide (Mounjaro) 20mg UK | GLP-1 Research Peptide
Buy Tirzepatide (Mounjaro) 20mg UK | GLP-1 Research Peptide
Buy Tirzepatide (Mounjaro) 20mg UK | GLP-1 Research Peptide
Buy Tirzepatide (Mounjaro) 20mg UK | GLP-1 Research Peptide — Tirzepatide 20mg research peptide supplied for laboratory research purposes. Tirzepatide is a synthetic dual agonist peptide targeting both the GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptors simultaneously, manufactured to ≥99% purity and HPLC-verified for use in scientific research. Dispatched from the UK with a Certificate of Analysis available upon request.
For in-vitro and laboratory research use only. Not for human or animal consumption, personal use, or self-administration.
Kit Contents
- 1 × vial of Tirzepatide 20mg (lyophilised)
- 1 × 3ml vial of bacteriostatic water
Tirzepatide 20mg Research Information
Tirzepatide (LY3298176) is a synthetic dual incretin receptor agonist developed by Eli Lilly and Company, commercially known as Mounjaro. As a GLP-1 and GIP dual agonist research peptide, it has been extensively studied in preclinical and clinical research for its effects on metabolic pathways, insulin signalling, energy homeostasis, and adipose tissue biology. Published Phase 3 SURPASS trial data demonstrated significant effects on glucose regulation and body weight across a range of doses, making it a subject of broad scientific interest in metabolic research disciplines.
Areas of Scientific Interest
- Dual incretin receptor agonism (GLP-1 and GIP)
- Metabolic rate and energy expenditure research
- Adipose tissue biology and lipid metabolism
- Insulin sensitivity and glucose homeostasis models
- Comparative agonist pharmacology across incretin receptor subtypes
- Body weight regulation and energy balance research
Product Specifications
- Product: Tirzepatide (Mounjaro)
- Quantity: 20mg
- Format: Lyophilised powder
- Purity: ≥99%
- Verification: HPLC-tested, Certificate of Analysis available
- Intended use: Research purposes only
- Storage: Store at −20°C, away from light and moisture
- Dispatched from the UK
Research Applications
Tirzepatide 20mg is of significant interest across metabolic biology, endocrinology, and diabetes research disciplines. Studies have investigated its role in dual incretin receptor agonism, adipose tissue remodelling, and glucose homeostasis. All applications are strictly for qualified laboratory research use.
Storage & Handling
Store lyophilised Tirzepatide 20mg at −20°C, protected from light and moisture. Reconstitute with the supplied bacteriostatic water under sterile conditions immediately prior to use. Once reconstituted, store at 4°C and use within recommended timeframes.
Frequently Asked Questions
What is Tirzepatide 20mg?
Tirzepatide 20mg is a synthetic GLP-1 and GIP dual agonist research peptide, also known as Mounjaro, supplied strictly for in-vitro and laboratory research purposes.
Is Tirzepatide 20mg available in the UK?
Yes. Tirzepatide 20mg GLP-1 research peptide is dispatched from the UK with a Certificate of Analysis available upon request.
What purity is your Tirzepatide 20mg?
All Tirzepatide 20mg vials are manufactured to ≥99% purity and independently HPLC-verified.
Can I buy Tirzepatide (Mounjaro) 20mg in the UK for research?
Tirzepatide 20mg is available for qualified laboratory research applications. It is not intended for human or animal use.
For research use only. Not for human consumption, therapeutic use, or veterinary use.
Related research peptides: Retatrutide 20mg Vial, Retatrutide 40mg Vial, MOTS-C 10mg, NAD+ 500mg. View our full research peptide range.